IDIBELL celebrates the first edition of its Accelerator Meeting Point The Bellvitge Biomedical Research Institute (IDIBELL) held yesterday April 16th the first edition of its Accelerator Meeting Point, a meeting where CataloniaBio -association of biomedicine and health companies in Catalonia-, Biocat -institution responsible for the promotion of the life sciences and health sector in Catalonia- […]
Bringing research closer to the industry Read More »
On April 13th and 14th, IDIBELL held its annual scientific retreat at the Bellvitge Cultural Center. During two days that were attended by more than 150 people between group leaders, principal investigators and external collaborators, IDIBELL presented its research programs and gave the firing shot to the preparation of the new Strategic Plan 2018-2021. The
IDIBELL redefines itself in its annual Retreat Read More »
The group of Dr. Conxi Lázaro, principal investigator of the Hereditary cancer research group of the Oncobell program (IDIBELL) and head of the Molecular Diagnostic Unit of the Hereditary Cancer Program (ICO), has received one of the Neurofibromatosis Research Grants of the Neurofibromatosis Proyecto Foundation in its Call 2018. The two-year grant, worth € 40,000,
€ 40,000 to move forward developing therapies against MPNST Read More »
Researchers led by Dr. Virginia Nunes (IDIBELL, UB, CiBERER U730) and Dr. Manuel Palacín (IRBB, UB, CIBERER U731) have demonstrated, for the first time, in vivocooperation of two basolateral transporters of neutral amino acids and their involvement in the renal reabsorption of these amino acids. The work, published in the Journal of the American Society of Nephrology (JASN),
The Oncobell sarcoma research group of the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Òscar Martínez-Tirado, has identified a potential new therapeutic target for Ewing sarcoma, the second most frequent bone cancer in children and adolescents, and a tumor known by its aggressiveness and tendency to metastasize. The research, published in International Journal of Cancer, has
A potential new therapeutic target for Ewing sarcoma Read More »
The IDIBELL Business development and Innovation area, led by Raquel Egea, has obtained the TECNIO certification as a “Public Technology Facilitator”. TECNIO is the seal granted by the Generalitat de Catalunya through ACCIÓ to identify Catalan differential technology, the providers that offer it and the facilitators involved in the process of technology and knowledge transfer,
IDIBELL obtains the TECNIO certification as a public technology facilitator Read More »
Last Friday, March 16th, the third edition of IDIBELL PhD Day took place at Duran i Reynals Hospital. This scientific symposium, organized by the predoctoral researchers of the Bellvitge Campus, aims to promote the research carried out by this researchers and encourage collaborations among the research groups they belong to. This year, approximately 150 people
The IDIBELL PhD Day grows stronger in its third edition Read More »
Researchers Oren Contreras-Rodríguez and Carlos Soriano-Mas, from the Psychiatry and Mental Health research group of the Neurosciences program of the Bellvitge Biomedical Research Institute (IDIBELL), have been awarded a Llavor grant from the Knowledge Industry Program of the Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement of the Generalitat of Catalonia to carry out a project
Manel Esteller, head of the Epigenetics and Cancer Biology Program at IDIBELL, ICREA researcher and professor of genetics at the University of Barcelona, is the biomedical scientist with projects in Spain most cited by other scientists, according to the latest edition of the Webometrics classification, published on February 26th by the cybermetrics group of the
IDIBELL’s researcher Manel Esteller is the most cited Spain-based biomedical scientist Read More »
Manel Esteller, Director of the Epigenetics and Cancer Biology Program at IDIBELL, ICREA Researcher and Professor of Genetics at the University of Barcelona, is the recipient of the Innovation Award in the Healthcare Field in Oncology, awarded by the Celgene Chair of Innovation in Health and the University of Alcalá. The award was given yesterday
Dr. Manel Esteller, Award for Innovation in the Healthcare Field in Oncology Read More »
